Netconsult S.R.L.
- Address
- Strada Roscani 18, 700141 Iasi, Romania
Netconsult S.R.L. - Respiratory Medicine Research Center
Netconsult S.R.L. is a specialized clinical research center with extensive expertise in respiratory medicine, focusing primarily on chronic pulmonary diseases. The center has established itself as a leading site for evaluating novel therapeutic approaches and combination therapies for patients suffering from debilitating respiratory conditions.
- Chronic Obstructive Pulmonary Disease (COPD) and maintenance triple therapy optimization
- Idiopathic Pulmonary Fibrosis (IPF) treatment development
- Novel add-on therapies for chronic bronchitis and COPD exacerbation prevention
The center demonstrates particular strength in conducting complex long-term trials evaluating fixed-dose combination therapies and add-on treatments to triple therapy regimens (ICS, LABA, LAMA combinations). Their research portfolio includes dose-response studies, efficacy and safety evaluations, and comparative trials designed to reduce moderate and severe COPD exacerbations. With experience in both dry powder inhaler (DPI) formulations and systemic therapies, Netconsult S.R.L. provides comprehensive assessment of respiratory interventions, measuring critical outcomes including lung function parameters such as forced expiratory volume (FEV1) and long-term tolerability profiles.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Chiesi Farmaceutici S.p.A.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Netconsult S.R.L.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Tanimilast (CHF6001) as an Add-On to Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease and Chronic Bronchitis | Chiesi Farmaceutici S.p.A. | Phase III | Not Recruiting | Jun 2021 | Jun 2025 |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Tanimilast | 2 | Unknown | 2021-06-16 | 2021-06-17 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.